The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances: Miniperspective
Open accessAbstract
The use of privileged structures in drug discovery has proven to be an effective strategy, allowing the generation of innovative hits/leads and successful optimization processes. Chromone is recognized as a privileged structure and a useful template for the design of novel compounds with potential pharmacological interest, particularly in the field of neurodegenerative, inflammatory, and infectious diseases as well as diabetes and cancer. This perspective provides the reader with an update of an earlier article entitled "Chromone: A Valid Scaffold in Medicinal Chemistry" ( Chem. Rev. 2014 , 114 , 4960 - 4992 ) and is mainly focused on chromones of biological interest, including those isolated from natural sources. Moreover, as drug repurposing is becoming an attractive drug discovery approach, recent repurposing studies of chromone-based drugs are also reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
Disordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107
Transmembrane TNF- : structure, function and interaction with anti-TNF agents
Horiuchi, T., Mitoma, H., Harashima, S.-I., Tsukamoto, H., & Shimoda, T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq031 · Cited by 864
Chromone: A Valid Scaffold in Medicinal Chemistry
Gaspar, A., Matos, M. J., Garrido, J., Uriarte, E., & Borges, F. (2014) · Chemical Reviews · doi:10.1021/cr400265z · Cited by 760
Self-citationKynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35
Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 687
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
Weckbecker, G., Lewis, I., Albert, R., Schmid, H. A., Hoyer, D., & Bruns, C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1255 · Cited by 559
Peptidomimetics, a synthetic tool of drug discovery
Vagner, J., Qu, H., & Hruby, V. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.03.009 · Cited by 538
Chromones as a privileged scaffold in drug discovery: A review
Keri, R. S., Budagumpi, S., Pai, R. K., & Balakrishna, R. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.047 · Cited by 500
Exploring the specificity of the PI3K family inhibitor LY294002
Gharbi, S. I., Zvelebil, M. J., Shuttleworth, S. J., Hancox, T., Saghir, N., Timms, J. F., & Waterfield, M. D. (2007) · Biochemical Journal · doi:10.1042/bj20061489 · Cited by 462
Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
Finberg, J. P. M., & Rabey, J. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00340 · Cited by 432
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310843 · Cited by 426
Puls, W., Keup, U., Krause, H. P., Thomas, G., & Hoffmeister, F. (1977) · Naturwissenschaften · doi:10.1007/bf00483562 · Cited by 419
The natural history of antibiotics
Clardy, J., Fischbach, M. A., & Currie, C. R. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.001 · Cited by 402
The Hedgehog's tale: developing strategies for targeting cancer
Ng, J. M. Y., & Curran, T. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3079 · Cited by 398
Barnes, P. J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1524 · Cited by 280
Pizzichini, E., Pizzichini, M. M., Efthimiadis, A., Dolovich, J., & Hargreave, F. E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70082-4 · Cited by 229
Lu, C., Guo, Y., Yan, J., Luo, Z., Luo, H.-B., Yan, M., Huang, L., & Li, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400567s · Cited by 226
A DOUBLE-BLIND TRIAL OF DISODIUM CROMOGLYCATE IN THE TREATMENT OF ALLERGIC BRONCHIAL ASTHMA
Howell, J. B. L., & Altounyan, R. E. C. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90499-0 · Cited by 219
New Frontiers in Selective Human MAO-B Inhibitors: Miniperspective
Carradori, S., & Silvestri, R. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501690r · Cited by 217
Andrš, M., Korábečný, J., Jun, D., Hodný, Z., Bártek, J., & Kuča, K. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501026z · Cited by 166
Serotonin 5-HT6Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease
Benhamú, B., Martín-Fontecha, M., Vázquez-Villa, H., Pardo, L., & López-Rodríguez, M. L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5003952 · Cited by 158
Yang, Y., Lu, J. Y.-L., Wu, X., Summer, S., Whoriskey, J. S., Saris, C. J. M., & Reagan, J. D. (2010) · Pharmacology · doi:10.1159/000314164 · Cited by 144
Renin–angiotensin–aldosterone system and myocardial fibrosis
Brilla, C. G. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00092-4 · Cited by 133
Seifert, T., Malo, M., Kokkola, T., Engen, K., Fridén‐Saxin, M., Wallén, E. A. A., Lahtela-Kakkonen, M. K., Jarho, E. M., & Luthman, K. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500930h · Cited by 125
Expression of functional GPR35 in human iNKT cells.
Fallarini, S., Magliulo, L., Paoletti, T., de Lalla, C., & Lombardi, G. (2010) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2010.06.091 · Cited by 123
Feng, L., Maddox, M. M., Alam, M. Z., Tsutsumi, L. S., Narula, G. S., Bruhn, D. F., Wu, X., Sandhaus, S., Lee, R. B., Simmons, C. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500853v · Cited by 114
Reis, J., Cagide, F., Chavarria, D., Silva, T., Fernandes, C., Gaspar, A., Uriarte, E., Remião, F., Alcaro, S., Ortuso, F., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00527 · Cited by 111
Self-citationValdameri, G., Genoux‐Bastide, E., Pérès, B., Gauthier, C., Guitton, J., Terreux, R., Winnischofer, S. M. B., Rocha, M. E. M., Boumendjel, A., & Pietro, A. D. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201404w · Cited by 102
Luo, Q., Sun, Y., Liu, W., Cheng, Q., Jin, B., Tao, F., Gu, Y., Wu, X., Shen, Y., & Xu, Q. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300832 · Cited by 99
G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease
Divorty, N., Mackenzie, A. E., Nicklin, S. A., & Milligan, G. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00041 · Cited by 98
Liu, K., Xu, L., Szalkowski, D., Li, Z., Ding, V. D. H., Kwei, G. Y., Huskey, S.-E. W., Moller, D. E., Heck, J. V., Zhang, B. B., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000285q · Cited by 89
Sun, Y. V., Bielak, L. F., Peyser, P. A., Turner, S. T., Sheedy, P. F., Boerwinkle, E., & Kardia, S. L. R. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20309 · Cited by 81
Takayama, H., Jia, Z., Kremer, L., Bauer, J. O., Carsten Strohmann, B., Ziegler, S., Antonchick, A. P., & Waldmann, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201306948 · Cited by 81
Habib, M., & Waheed, I. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.10.022 · Cited by 72
Inflammatory signal transduction from the FcεRI to NF-κB
Klemm, S., & Ruland, J. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.07.001 · Cited by 71
Cano, P., Islas‐Jácome, A., Marrero, J. G., Yépez‐Mulia, L., Calzada, F., & Gámez‐Montaño, R. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.069 · Cited by 66
Nazreen, S., Alam, M. S., Hamid, H., Yar, M. S., Dhulap, A., Alam, P., Pasha, M. A. Q., Bano, S., Alam, M. M., Haider, S., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.034 · Cited by 63
Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors
Helguera, A. M., Pérez-Garrido, A., Gaspar, A., Reis, J., Cagide, F., Viña, D., Cordeiro, M. N. D. S., & Borges, F. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.035 · Cited by 62
Self-citationZhu, W., Chen, C., Sun, C., Xu, S., Wu, C., Lei, F., Xia, H., Tu, Q., & Zheng, P. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.061 · Cited by 61
Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization
Basavarajappa, H. D., Lee, B., Lee, H., Sulaiman, R. S., An, H., Magaña, C., Shadmand, M., Vayl, A., Gangaraju, R., Kim, E.-Y., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00449 · Cited by 61
Liu, Q., Qiang, X., Li, Y., Sang, Z., Li, Y., Tan, Z., & Deng, Y. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.042 · Cited by 60
Sophoricoside Analogs as the IL-5 Inhibitors from Sophora japonica
Min, B., Oh, S., Lee, H., Takatsu, K., Chang, I., Min, K. R., & Kim, Y. (1999) · Planta Medica · doi:10.1055/s-1999-14016 · Cited by 58
Nikam, A. P., Ollivier, A., Rivard, M., Wilson, J. L., Mebarki, K., Martens, T., Dubois‐Randé, J., Motterlini, R., & Foresti, R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01509 · Cited by 57
Zwergel, C., Valente, S., Salvato, A., Xu, Z., Talhi, O., Mai, A., Silva, A. M. S., Altucci, L., & Kirsch, G. (2013) · MedChemComm · doi:10.1039/c3md00241a · Cited by 53
Novel approaches to drug discovery for the treatment of type 2 diabetes
Xu, X. Y., Wang, G., Zhou, T., Chen, L., Chen, J., & Shen, X. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.941352 · Cited by 52
Rikimaru, K., Wakabayashi, T., Abe, H., Imoto, H., Maekawa, T., Ujikawa, O., Murase, K., Matsuo, T., Matsumoto, M., Nomura, C., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.008 · Cited by 52
A new 2-(2-phenylethyl)chromone derivative in Chinese agarwood ‘Qi-Nan’ from Aquilaria sinensis
Yang, D., Wang, H., Guo, Z., Dong, W.-H., Mei, W.-L., & Dai, H. (2014) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2014.896342 · Cited by 52
Griffith, D. A., Dow, R. L., Huard, K., Edmonds, D. J., Bagley, S. W., Polívková, J., Zeng, D., García-Irizarry, C. N., Southers, J. A., Esler, W. P., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401033t · Cited by 49
Lee, H., Shin, J., Lee, W., Ryu, B., Jang, D. S., & Lee, K. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00609 · Cited by 49
Novel “Second-Generation” Approaches for the Control of Type 2 Diabetes
Rotella, D. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030626a · Cited by 47
Tang, S., Ji, M., Chen, L., Hu, M. Y., Long, Y., Li, Y., Miao, M., Li, J.-C., Li, N., Ji, H., et al. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001314 · Cited by 45
Grażul, M., Gyenge, E. B., Maake, C., Ciołkowski, M., Czyż, M., Sigel, R. K. O., & Budzisz, E. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.02.014 · Cited by 44
Şabudak, T., Demirkiran, Ö., Öztürk, M., & Topçu, G. (2013) · Phytochemistry · doi:10.1016/j.phytochem.2013.08.014 · Cited by 44
Mechanisms of current therapies for diabetes mellitus type 2
Thulé, P. M. (2012) · AJP Advances in Physiology Education · doi:10.1152/advan.00094.2012 · Cited by 43
Winter, E., Lecerf-Schmidt, F., Gozzi, G. J., Pérès, B., Lightbody, M., Gauthier, C., Özvegy‐Laczka, C., Szakács, G., Sarkadi, B., Creczynski‐Pasa, T. B., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401649j · Cited by 42
Jawale, D. V., Pratap, U. R., Rahuja, N., Srivastava, A. K., & Mane, R. A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.110 · Cited by 39
Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization
Obreque-Balboa, J. E., Sun, Q., Bernhardt, G., König, B., & Buschauer, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.12.010 · Cited by 39
Parveen, M., Malla, A. M., Yaseen, Z., Ali, A. A., & Alam, M. (2013) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2013.11.019 · Cited by 38
Funke, M., Thimm, D., Schiedel, A. C., & Müller, C. E. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400587g · Cited by 36
Kim, J., Jung, S.-H., Yang, Y., Ahn, J., Cho, J., Lee, K., Baek, N., & Choi, J. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.12.003 · Cited by 35
Spijkers-Hagelstein, J. A. P., Pinhanços, S. S., Schneider, P., Pieters, R., & Stam, R. W. (2013) · Leukemia · doi:10.1038/leu.2013.245 · Cited by 34
Takao, K., Yamashita, M., Yashiro, A., & Sugita, Y. (2016) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c16-00327 · Cited by 34
ABCG2: Recent Discovery of Potent and Highly Selective Inhibitors
Lecerf-Schmidt, F., Pérès, B., Valdameri, G., Gauthier, C., Winter, E., Payen, L. F., Pietro, A. D., & Boumendjel, A. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.71 · Cited by 31
Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis
Gobbi, S., Hu, Q., Zimmer, C., Engel, M., Belluti, F., Rampa, A., Hartmann, R. W., & Bisi, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01609 · Cited by 26
Fisher, A., Friel, E. C., Bernhardt, R., Gómez-Sánchez, C. E., Connell, J., Fraser, R., & Davies, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7797 · Cited by 25
Zhou, Y., ZHU, L. B., Peng, A. F., Wang, T. F., LONG, X. H., GAO, S., ZHOU, R. P., & Liu, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2787 · Cited by 24
Ma, J., Xie, S., Geng, Y., Jin, S., Wang, G., & Lv, G. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.06.012 · Cited by 22
In Vivo Imaging of Multidrug Resistance Using a Third Generation MDR1 Inhibitor
Sprachman, M. M., Laughney, A. M., Köhler, R. H., & Weissleder, R. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500154c · Cited by 22
Nadmid, S., Plaza, A., Garcia, R., et al. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00343 · Cited by 15
Cited by
Polyphenols: A concise overview on the chemistry, occurrence, and human health
Durazzo, A., Lucarini, M., Souto, E. B., Cicala, C., Caiazzo, E., Izzo, A. A., Novellino, E., & Santini, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6419 · Cited by 802
Delost, M. D., Smith, D. T., Anderson, B. J., & Njardarson, J. T. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00876 · Cited by 409
Multi-objective de novo drug design with conditional graph generative model
Li, Y., Zhang, L., & Liu, Z. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0287-6 · Cited by 376
Metadata
- Authors
- Reis, J., Gaspar, A., Milhazes, N., & Borges, F.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-06-13
- Volume
- 60
- Issue
- 19
- Pages
- 7941-7957
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2620296850
- Cited by
- 414
- References
- 71
- FWCI
- 18.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.